Protagonist Therapeutics (PTGX) Reports Q4 Loss of $0.15
Tweet
Share
E-mailGet Alerts PTGX Hot Sheet
Join SI Premium – FREE
Protagonist Therapeutics (NASDAQ: PTGX) reported Q4 EPS of ($0.15), versus ($0.67) reported last year.
For earnings history and earnings-related data on Protagonist Therapeutics (PTGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Alimentation Couche-Tard Inc (ATD/B:CN) (ANCUF) PT Raised to Cdn$104 at UBS
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
